Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study

Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8:151–7.BallardCHanneyMLTheodoulouMDouglasSMcShaneRKossakowskiKet alThe dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trialLancet Neurol20098151–710.1016/S1474-4422(08)70295-3Search in Google Scholar

Beovic B, Plesnicar BK, Potocan M. Antibiotic prescribing in psychiatric hospitals and interactions between antibiotics and psychotropic drugs: a prospective observational study. Infect Control Hosp Epidemiol. 2016;37:233–235. doi: 10.1017/ ice.2015.268.BeovicBPlesnicarBKPotocanMAntibiotic prescribing in psychiatric hospitals and interactions between antibiotics and psychotropic drugs: a prospective observational studyInfect Control Hosp Epidemiol201637233–23510.1017/ice.2015.268Open DOISearch in Google Scholar

Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004;161:700–6.CentorrinoFGorenJLHennenJSalvatorePKelleherJPBaldessariniRJMultiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefitsAm J Psychiatry2004161700–610.1176/appi.ajp.161.4.700Search in Google Scholar

Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta analysis. Lancet. 2009;373:746–58.CiprianiAFurukawaTASalantiGGeddesJRHigginsJPChurchillRet alComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta analysisLancet2009373746–5810.1016/S0140-6736(09)60046-5Search in Google Scholar

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, et al. Advantages and disadvantages of combination treatment with antipsychotics, ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol. 2009;19:520–532.GoodwinGFleischhackerWArangoCBaumannPDavidsonMde HertMet alAdvantages and disadvantages of combination treatment with antipsychotics, ECNP Consensus Meeting, March 2008, NiceEur Neuropsychopharmacol200919520–53210.1016/j.euroneuro.2009.04.00319411165Search in Google Scholar

Gören JL, Beck SE, Mills BJ, Shtasel DL, Dufresne RL. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy. J Manag Care Pharm. 2010;16:393–401.GörenJLBeckSEMillsBJShtaselDLDufresneRLDevelopment and delivery of a quality improvement program to reduce antipsychotic polytherapyJ Manag Care Pharm201016393–40110.18553/jmcp.2010.16.6.39320635830Search in Google Scholar

Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World Federation of Societies of Biological Psychiatry (WFSBP). World J Biol Psychiatry. 2012;13:318–378.HasanAFalkaiPWobrockTLiebermanJGlenthojBGattazWFet alWorld Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistanceWorld Federation of Societies of Biological Psychiatry (WFSBP). World J Biol Psychiatry201213318–37810.3109/15622975.2012.69614322834451Search in Google Scholar

Hashimoto Y, Tensho M. Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study. BMC Health Serv Res. 2016;26;16:150.HashimotoYTenshoMEffect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post studyBMC Health Serv Res2016261615010.1186/s12913-016-1408-4484719027117589Search in Google Scholar

Hazra M, Uchida H, Sproule B, Remington G, Suzuki T, Mamo DC. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry Clin Neurosci. 2011;65:676–8.HazraMUchidaHSprouleBRemingtonGSuzukiTMamoDCImpact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophreniaPsychiatry Clin Neurosci201165676–810.1111/j.1440-1819.2011.02280.x22176287Search in Google Scholar

Heun R. How to write a scientific paper: A hypothesis-based approach. Global Psychiatry. 2018;1(1):3-6. doi: https://doi.org/10.2478/gp-2018–0004HeunRHow to write a scientific paper: A hypothesis-based approachGlobal Psychiatry2018113–6https://doi.org/10.2478/gp-2018–000410.2478/gp-2018-0004Search in Google Scholar

Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.HoltSSchmiedlSThürmannPAPotentially inappropriate medications in the elderly: the PRISCUS listDtsch Arztebl Int2010107543–51Search in Google Scholar

Holzapfel E, Szabo C. Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population. Global Psychiatry. 2018;1(2):39-51. doi: https://doi.org/10.2478/gp-2018-0006HolzapfelESzaboCPharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient populationGlobal Psychiatry20181239–51https://doi.org/10.2478/gp-2018-000610.2478/gp-2018-0006Search in Google Scholar

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, et al. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med. 2006;354:472–82.HonerWGThorntonAEChenEYChanRCWongJOBergmannAet alClozapine alone versus clozapine and risperidone with refractory schizophreniaN Engl J Med2006354472–8210.1056/NEJMoa05322216452559Search in Google Scholar

Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation, Br J Psychiatry. 2012;201:481–485.HowesODVergunstFGeeSMcGuirePKapurSTaylorDAdherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation, Br J Psychiatry2012201481–48510.1192/bjp.bp.111.10583322955007Search in Google Scholar

Krause M, Huhn M, Schneider-Thoma J, Rothe P, Smith RC, Leucht S. Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2018;28(12):1360–1370.KrauseMHuhnMSchneider-ThomaJRothePSmithRCLeuchtSAntipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysisEur Neuropsychopharmacol201828121360–137010.1016/j.euroneuro.2018.09.00730243680Search in Google Scholar

Lexicomp® drug-drug interaction checker. Accessed October 10, 2017: https://www.uptodate.comLexicomp® drug-drug interaction checkerAccessed October 102017https://www.uptodate.comSearch in Google Scholar

Mann E, Haastert B, Böhmdorfer B, Frühwald T, Iglseder B, Roller-Wirnsberger R, et al. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr. 2013;125:180–188.MannEHaastertBBöhmdorferBFrühwaldTIglsederBRoller-WirnsbergerRet alPrevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional studyWien Klin Wochenschr2013125180–18810.1007/s00508-013-0342-223536016Search in Google Scholar

Marušič Premuš A. Pharmacotherapy reviews in hospitals and at an outpatient clinic Farmakoterapijski pregledi v bolnišnicah in v ambulantah – izkušnje in evalvacija dela. Farmacevtski vestnik. 2014;65:187–190.MarušičPremuš A.Pharmacotherapy reviews in hospitals and at an outpatient clinic Farmakoterapijski pregledi v bolnišnicah in v ambulantah – izkušnje in evalvacija delaFarmacevtski vestnik201465187–190Search in Google Scholar

Meesters PD, de Haan L, Comijs HC, Stek ML, Smeets-Janssen MM, Weeda MR, et al. Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment area. Am J Geriatr Psychiatry. 2012;20:18–28.MeestersPDde HaanLComijsHCStekMLSmeets-JanssenMMWeedaMRet alSchizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment areaAm J Geriatr Psychiatry20122018–2810.1097/JGP.0b013e3182011b7f22183010Search in Google Scholar

O’Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 2016;6(4):e010505.O’DwyerMPeklarJMcCallionPMcCarronMHenmanMCFactors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide studyBMJ Open201664e01050510.1136/bmjopen-2015-010505482345827044582Search in Google Scholar

Quality and Outwork framework 2012 (Accessed on 27 of January 2018): https://www.nhsemployers.org/Quality and Outwork framework2012(Accessed on 27 of January 2018)https://www.nhsemployers.org/Search in Google Scholar

Rieckert A, Trampisch US, Klaaßen-Mielke R, Drewelow E, Esmail A, Johansson T, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19(1):113. doi: 10.1186/s12875-018-0795-5.RieckertATrampischUSKlaaßen-MielkeRDrewelowEEsmailAJohanssonTet alPolypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacyBMC Fam Pract201819111310.1186/s12875-018-0795-5605259230021528Open DOISearch in Google Scholar

Schumacher JE, Makela EH, Griffin HR. Multiple antipsychotic medication prescribing patterns. Ann Pharmacother. 2003;37:951– 5.SchumacherJEMakelaEHGriffinHRMultiple antipsychotic medication prescribing patternsAnn Pharmacother200337951–95510.1345/aph.1C42012841799Search in Google Scholar

Stahl SM. Emerging guidelines for the use of antipsychotic polypharmacy. Rev Psiquiatr Salud Ment. 2013;6:97–100.StahlSMEmerging guidelines for the use of antipsychotic polypharmacyRev Psiquiatr Salud Ment2013697–10010.1016/j.rpsmen.2013.01.001Search in Google Scholar

Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19(1):118.StuhecMGorencKZelkoEEvaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementationBMC Health Serv Res201919111810.1186/s12913-019-3942-3Search in Google Scholar

Stuhec M, Serra-Mestres J. Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline, Global Psychiatry. 2018;1(1):17–24. doi: https://doi.org/10.2478/gp-2018-0005StuhecMSerra-MestresJAntidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline, Global Psychiatry20181117–24https://doi.org/10.2478/gp-2018-000510.2478/gp-2018-0005Search in Google Scholar

Stuhec M. Pharmacotherapy review as a safety and cost tool in patients management in Slovenian Psychiatric Hospital. V: Abstracts of the 27th ECNP Congress, Berlin, Germany, 18-21 October 2014. European Neuropsychopharmacology. 2014;24:S735–S736.StuhecMPharmacotherapy review as a safety and cost tool in patients management in Slovenian Psychiatric Hospital. V: Abstracts of the 27th ECNP Congress, Berlin, Germany, 18-21 October 2014European Neuropsychopharmacology201424S735–S73610.1016/S0924-977X(14)71185-XSearch in Google Scholar

Stuhec M, Gorenc K. Clinical pharmacist interventions in elderly patients in primary care treated with polypharmacy and psychotropics: Observational retrospective study. European Neuropsychopharmacology. 2019;29:S545–S546StuhecMGorencKClinical pharmacist interventions in elderly patients in primary care treated with polypharmacy and psychotropics: Observational retrospective studyEuropean Neuropsychopharmacology201929S545–S54610.1016/j.euroneuro.2018.11.805Search in Google Scholar

Summary of Product Characteristics (SmPC) of sulpiride. Accessed October 10, 2017: https://www.medicines.org.uk/emc/product/2430/smpcSummary of Product Characteristics (SmPC) of sulpirideAccessed October 102017https://www.medicines.org.uk/emc/product/2430/smpcSearch in Google Scholar

Suzuki T, Uchida H, Watanabe K, Yagi G, Kashima H. A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(2):361–9.SuzukiTUchidaHWatanabeKYagiGKashimaHA clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry2004282361–910.1016/j.pnpbp.2003.11.00614751434Search in Google Scholar

Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry. 2003;64:30–34.TaylorDMYoungCPatonCPrior antipsychotic prescribing in patients currently receiving clozapine: a case note reviewJ Clin Psychiatry20036430–3410.4088/JCP.v64n010712590620Search in Google Scholar

Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry. 2019 Feb 20. doi: 10.1001/ jamapsychiatry.2018.4320.TiihonenJTaipaleHMehtäläJVattulainenPCorrellCUTanskanenAAssociation of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With SchizophreniaJAMA Psychiatry2019Feb 20. doi10.1001/jamapsychiatry.2018.4320649535430785608Open DOISearch in Google Scholar

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–49.von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJ Clin Epidemiol2008614344–4910.1016/j.jclinepi.2007.11.00818313558Search in Google Scholar

Wilson SJ. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24:1577–601.WilsonSJBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disordersJ Psychopharmacol2010241577–60110.1177/026988111037930720813762Search in Google Scholar